Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing ; volume:63 ; number:11 ; day:23 ; month:10 ; year:2024 ; pages:1547-1560 ; date:11.2024
Clinical pharmacokinetics ; 63, Heft 11 (23.10.2024), 1547-1560, 11.2024
- Creator
-
Ashraf, Muhammad Waqar
Poikola, Satu
Neuvonen, Mikko
Kiiski, Johanna I.
Kontinen, Vesa K.
Olkkola, Klaus T.
Backman, Janne T.
Niemi, Mikko
Saari, Teijo I.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-024-01433-9
- URN
-
urn:nbn:de:101:1-2502042104312.747544944538
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ashraf, Muhammad Waqar
- Poikola, Satu
- Neuvonen, Mikko
- Kiiski, Johanna I.
- Kontinen, Vesa K.
- Olkkola, Klaus T.
- Backman, Janne T.
- Niemi, Mikko
- Saari, Teijo I.
- SpringerLink (Online service)
Other Objects (12)
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
Precision dosing of risperidone and aripiprazole in the treatment of schizophrenia using a physiologically based pharmacokinetic approach: a focus on the genetic polymorphism of CYP2D6
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting
Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
Precision dosing of risperidone and aripiprazole in the treatment of schizophrenia using a physiologically based pharmacokinetic approach: a focus on the genetic polymorphism of CYP2D6
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting
Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
Precision dosing of risperidone and aripiprazole in the treatment of schizophrenia using a physiologically based pharmacokinetic approach: a focus on the genetic polymorphism of CYP2D6
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting